Health ❯Healthcare ❯Pharmaceuticals ❯Drug Regulation

FDA

Sarepta Temporarily Halts Elevidys Shipments Under FDA Request

The company will suspend distribution to complete mandated safety labeling under FDA oversight.

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

Eli Lilly Fights Back Against Compounded Tirzepatide Amid FDA Supply Resolution

FDA Declares End to Tirzepatide Shortage, Impacting Compounded Drug Market